CL 12.5 (Tetrabenazine 12.5 mg)
Pill imprint CL 12.5 has been identified as Tetrabenazine 12.5 mg.
Tetrabenazine is used in the treatment of huntington's disease; tardive dyskinesia and belongs to the drug class miscellaneous central nervous system agents. Risk cannot be ruled out during pregnancy. Tetrabenazine 12.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about tetrabenazine
- Other brands: Xenazine
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.